NO943616L - Piperidine and piperazine - Google Patents

Piperidine and piperazine

Info

Publication number
NO943616L
NO943616L NO943616A NO943616A NO943616L NO 943616 L NO943616 L NO 943616L NO 943616 A NO943616 A NO 943616A NO 943616 A NO943616 A NO 943616A NO 943616 L NO943616 L NO 943616L
Authority
NO
Norway
Prior art keywords
piperidine
chromen
chroman
hal
cor
Prior art date
Application number
NO943616A
Other languages
Norwegian (no)
Other versions
NO306948B1 (en
NO943616D0 (en
Inventor
Henning Bottcher
Christoph Seyfried
Gerd Bartoszyk
Hartmut Greiner
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO943616D0 publication Critical patent/NO943616D0/en
Publication of NO943616L publication Critical patent/NO943616L/en
Publication of NO306948B1 publication Critical patent/NO306948B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Piperidine and piperazine derivatives of the formula I <IMAGE> wherein Ind is an unsubstituted indol-3-yl radical or one which is mono- or disubstituted by OH, OA, CN, Hal, COR<2> or CH2R<2>, R' is benzofuran-5-yl or 2,3-dihydrobenzofuran-5-yl, chroman-6-yl, chroman-4-on-6-yl, 3-chromen-6-yl or chromen-4-on-6-yl which are unsubstituted or monosubstituted by CN, CH2OH, CH2OA or COR<2>, Q is CmH2m, Z is N or CR<3>, A is alkyl having 1-6 C atoms, Hal is F, Cl, Br or I, R<2> is OH, OA, NH2, NHA or NA2, R<3> is H, OH or OA and m is 2, 3 or 4, and their physiologically acceptable salts affect the central nervous system.
NO943616A 1993-09-30 1994-09-29 Piperidine and piperazine derivatives, pharmaceutical preparations containing such compounds, and the use of the compounds in the manufacture of medicinal products NO306948B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4333254A DE4333254A1 (en) 1993-09-30 1993-09-30 Piperidines and piperazines

Publications (3)

Publication Number Publication Date
NO943616D0 NO943616D0 (en) 1994-09-29
NO943616L true NO943616L (en) 1995-03-31
NO306948B1 NO306948B1 (en) 2000-01-17

Family

ID=6499013

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943616A NO306948B1 (en) 1993-09-30 1994-09-29 Piperidine and piperazine derivatives, pharmaceutical preparations containing such compounds, and the use of the compounds in the manufacture of medicinal products

Country Status (21)

Country Link
US (1) US5532241A (en)
EP (1) EP0648767B1 (en)
JP (2) JP4065034B2 (en)
KR (1) KR100341190B1 (en)
CN (1) CN1056610C (en)
AT (1) ATE153663T1 (en)
AU (1) AU679774B2 (en)
CA (1) CA2133152C (en)
CZ (1) CZ293558B6 (en)
DE (2) DE4333254A1 (en)
DK (1) DK0648767T3 (en)
ES (1) ES2105454T3 (en)
GR (1) GR3024551T3 (en)
HU (1) HU218918B (en)
NO (1) NO306948B1 (en)
PL (1) PL178137B1 (en)
RU (1) RU2132848C1 (en)
SK (1) SK281793B6 (en)
TW (1) TW313569B (en)
UA (1) UA34449C2 (en)
ZA (1) ZA947622B (en)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333254A1 (en) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidines and piperazines
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
FR2712591B1 (en) * 1993-11-19 1996-02-09 Pf Medicament New arylpiperazines derived from indole, their preparation and their therapeutic use.
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
DE19514567A1 (en) * 1995-04-20 1996-10-24 Merck Patent Gmbh Benzofurans
US6436940B2 (en) * 1996-12-20 2002-08-20 H. Lundbeck A/S Indane or dihydroindole derivatives
DE19730989A1 (en) * 1997-07-18 1999-01-21 Merck Patent Gmbh Piperazine derivatives
ES2206963T3 (en) 1997-07-25 2004-05-16 H. Lundbeck A/S DERIVATIVES OF INDOL AND 2,3-DIHYDROINDOL, ITS PREPARATION AND USE.
US6004982A (en) * 1997-09-15 1999-12-21 Hoechst Marion Roussel, Inc. 4-piperidinyl) H-2-benzopyran derivatives useful as antipsychotic agents
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6303627B1 (en) 1998-06-19 2001-10-16 Eli Lilly And Company Inhibitors of serotonin reuptake
DE19858340A1 (en) * 1998-12-17 2000-06-21 Merck Patent Gmbh Process for the preparation of 3-alkanoyl and 3-alkylindoles
IL146309A (en) * 1999-05-21 2008-03-20 Scios Inc INDOLE-TYPE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AS INHIBITORS OF p38 KINASE
TW518218B (en) * 1999-05-27 2003-01-21 Merck Patent Gmbh Pharmaceutical compositions comprising 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine or its physiologically acceptable salts for use in the treatment of sub-type anxiety disorders
US20120077825A1 (en) * 1999-05-27 2012-03-29 Merck Patentgesellschaft Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
DE19932314A1 (en) * 1999-07-10 2001-01-11 Merck Patent Gmbh Benzofuran derivatives
CA2379021C (en) * 1999-08-23 2009-10-27 Solvay Pharmaceuticals B.V. New phenylpiperazines
AU2002215027B2 (en) * 2000-11-14 2006-10-05 Merck Patent Gmbh Novel uses of combined 5-HT1A agonists and serotonin reuptake inhibitors
UA76130C2 (en) * 2000-11-20 2006-07-17 Merck Patent Gmbh Use of compounds combining properties of selective inhibitors of serotonin re-uptake and agonists of 5-ht1a receptor for treatment of irritable bowel syndrome
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
AR032712A1 (en) 2001-02-21 2003-11-19 Solvay Pharm Bv A MESILATE OF PHENYLPIPERAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
DE10112151A1 (en) * 2001-03-14 2002-09-19 Merck Patent Gmbh New 5-(4-(indolyl-alkyl)-piperazino)-benzofuran-2-carboxamides useful e.g. for treating depression, anxiety, psychiatric or cerebral disorders or pain, are 5-HT-1A receptor agonists and 5-HT reuptake inhibitors
US6656950B2 (en) * 2001-04-25 2003-12-02 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
UA76758C2 (en) 2001-06-19 2006-09-15 Мерк Патент Гмбх Polymorph forms of hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine
DE10217006A1 (en) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituted indoles
DE10259244A1 (en) * 2002-12-17 2004-07-01 Merck Patent Gmbh N- (Indolethyl-) cyclo amine compounds
AU2003299227A1 (en) * 2002-12-20 2004-07-14 Ciba Specialty Chemicals Holding Inc. Synthesis of amines and intermediates for the synthesis thereof
DE10305739A1 (en) * 2003-02-11 2004-08-19 Merck Patent Gmbh New indolyl-substituted benzofuran derivatives, are 5-HT(1A) agonists and 5-HT reuptake inhibitors useful e.g. as anxiolytic, antidepressant, neuroleptic and/or antihypertensive agents
DE10306941A1 (en) * 2003-02-18 2004-08-26 Merck Patent Gmbh New indolyl-substituted benzofuranyloxy-alkylamine derivatives, are 5-hydroxytryptamine reuptake inhibitors useful e.g. as anxiolytic, antidepressant, neuroleptic and/or antihypertensive agents
DE10315285A1 (en) 2003-04-04 2004-10-14 Merck Patent Gmbh Chromenonindole
DE10326940A1 (en) * 2003-06-16 2005-01-05 Merck Patent Gmbh Indole derivatives
DE10326939A1 (en) * 2003-06-16 2005-01-05 Merck Patent Gmbh Indole derivatives
DE102004063797A1 (en) * 2004-12-30 2006-07-13 Schwarz Pharma Ag Oxygenated fused phenylpiperazine and phenyldiazepane carboxamides
DE102005019670A1 (en) * 2005-04-26 2006-11-02 Merck Patent Gmbh Preparation of 5-(4-(4-(5-cyano-3-indolyl)-butyl)-1-piperazinyl)-benzofuran-2-carboxamide, comprises reacting a heterocyclic compound with a carbonitrile compound; and/or converting the obtained benzofuran compound to its salt
EP2110374A1 (en) * 2008-04-18 2009-10-21 Merck Sante Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
EA201171020A1 (en) 2009-03-10 2012-03-30 Такеда Фармасьютикал Компани Лимитед DERIVATIVES OF BENZOFURANE
US8877778B2 (en) * 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
WO2012131706A1 (en) 2011-03-20 2012-10-04 Cadila Healthcare Limited Amorphous form of vilazodone hydrochloride and process for its preparation
CN102219783B (en) * 2011-05-05 2013-07-03 天津市汉康医药生物技术有限公司 Vilazodone hydrochloride and composition thereof
CN102267932A (en) * 2011-06-15 2011-12-07 上海医药工业研究院 4-(5-cyano-1H-indole-3-yl) butyl substituted sulphonate compounds and use thereof
CN102267985B (en) * 2011-06-15 2015-12-09 上海医药工业研究院 The preparation method of vilazodone or its hydrochloride
CN102949364A (en) * 2011-08-30 2013-03-06 天津药物研究院 Sustained release tablet containing effective component hydrochloric acid vilazodone
US9505744B2 (en) 2011-11-23 2016-11-29 Assia Chemical Industries Ltd. Solid state forms of vilazodone and vilazodone hydrochloride
AU2012354150A1 (en) 2011-12-12 2014-07-03 Ranbaxy Laboratories Limited Amorphous vilazodone hydrochloride, a process for its preparation and pharmaceutical compositions thereof
ITMI20120531A1 (en) 2012-04-02 2013-10-03 Erregierre Spa PROCEDURE FOR THE PREPARATION OF VILAZODONE CHLORIDRATE
WO2013153492A2 (en) * 2012-04-12 2013-10-17 Alembic Pharmaceuticals Limited Process for the preparation of vilazodone hydrochloride and its amorphous form
EP2838894A1 (en) 2012-04-16 2015-02-25 Ranbaxy Laboratories Limited Process for the preparation of crystalline vilazodone hydrochloride
WO2013164794A1 (en) 2012-05-04 2013-11-07 Ranbaxy Laboratories Limited Crystalline forms of vilazodone hydrochloride
CN102659660B (en) * 2012-05-11 2014-07-02 杭州和泽医药科技有限公司 Preparation method and application of 3-(4-chlorobutyl)-5-cyano-1H-indole
WO2013175361A1 (en) 2012-05-24 2013-11-28 Ranbaxy Laboratories Limited Process for the preparation of vilazodone hydrochloride
US8835635B2 (en) 2012-06-05 2014-09-16 Symed Labs Limited Amorphous form of vilazodone hydrochloride substantially free of crystalline forms
WO2013182946A2 (en) * 2012-06-06 2013-12-12 Ranbaxy Laboratories Limited Process for the preparation of vilazodone hydrochloride
AU2013273868A1 (en) 2012-06-13 2015-02-05 Apotex Inc. Forms of Vilazodone and processes for the preparation thereof
WO2014005134A2 (en) * 2012-06-29 2014-01-03 Forest Laboratories Holdings Limited 4-(2-(6-substituted-hexylidene) hydrazinyl)benzonitrile and preparation thereof
WO2014006637A2 (en) 2012-07-02 2014-01-09 Symed Labs Limited Improved process for preparing benzofuran-2-carboxamide derivatives
CN102796037B (en) * 2012-08-09 2013-11-06 成都苑东药业有限公司 3-(4-(4-substituted-piperazino)-1-butyryl)indolyl-5-formonitrile and application thereof
WO2014028473A1 (en) 2012-08-13 2014-02-20 Assia Chemical Industries Ltd. New salts of vilazodone and solid state forms thereof
US9533949B2 (en) 2012-09-12 2017-01-03 Apotex Pharmachem Inc. Processes for the preparation of 3-alkyl indoles
WO2014049609A2 (en) 2012-09-26 2014-04-03 Cadila Healthcare Limited Novel salts of vilazodone
WO2014061004A2 (en) 2012-10-19 2014-04-24 Ranbaxy Laboratories Limited Process for the preparation of vilazodone or pharmaceutically acceptable salt thereof
WO2014061000A1 (en) 2012-10-19 2014-04-24 Ranbaxy Laboratories Limited Process for the preparation of vilazodone or pharmaceutically acceptable salt thereof
WO2014064715A2 (en) 2012-10-22 2014-05-01 Cadila Healthcare Limited Amorphous form of vilazodone hydrochloride and process for preparing thereof
CN102977083A (en) * 2012-12-17 2013-03-20 南京海纳医药科技有限公司 New crystal form XVII of 1-(4-(5-cyanoindole-3-yl) butyl)-4-(2-carbamyl-benzofuran-5-yl)-piperazine hydrochloride and preparation method of new crystal form XVII
CN102993186B (en) * 2012-12-20 2015-11-18 北京海步国际医药科技发展有限公司 A kind of novel bridged piperazine derivatives
ITMI20130392A1 (en) 2013-03-15 2014-09-16 Dipharma Francis Srl SYNTHESIS OF A SEROTONIN REPLACEMENT INHIBITOR
CN104098552A (en) * 2013-04-02 2014-10-15 上海医药工业研究院 Preparation method of vilazodone
WO2014178013A1 (en) 2013-04-30 2014-11-06 Ranbaxy Laboratories Limited Vilazodone impurities, process for their preparation, and their use as reference standards
IN2013MU02001A (en) 2013-06-12 2015-05-29 Lupin Ltd
CN103360373B (en) * 2013-07-12 2016-06-15 苏州永健生物医药有限公司 The synthetic method of vilazodone intermediate and salt thereof
EP2824104A1 (en) 2013-07-12 2015-01-14 Sandoz AG Process for the preparation of form III of Vilazodone hydrochloride
CN104337812B (en) 2013-07-29 2018-09-14 广东东阳光药业有限公司 Substituted heteroaryl compound and its application method and purposes
WO2015019237A1 (en) 2013-08-06 2015-02-12 Ranbaxy Laboratories Limited Pharmaceutical composition of vilazodone
WO2015019256A1 (en) 2013-08-06 2015-02-12 Ranbaxy Laboratories Limited Pharmaceutical composition of vilazodone and processes of preparation thereof
CN104725359B (en) 2013-12-20 2017-05-03 广东东阳光药业有限公司 Substituted piperazine compound as well as application method and application thereof
CN103709089B (en) * 2013-12-31 2015-08-19 南通恒盛精细化工有限公司 One prepares the method for 3-(4 '-chlorobutyl)-5-cyanoindole
WO2016128987A1 (en) * 2015-02-13 2016-08-18 Harman Finochem Limited A process for preparation of 2-benzofurancarboxamide, 5-[4-[4-(5cyano-1h-indol-3-yl)butyl]-1-piperazinyl] free base and its hydrochloride salt
WO2016142952A1 (en) * 2015-03-10 2016-09-15 Nosch Labs Private Limited Process for preparation of vilazodone and its novel intermediates
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
WO2018082557A1 (en) 2016-11-02 2018-05-11 Sunshine Lake Pharma Co., Ltd. Vilazodone inclusion complexes, compositions and preparation thereof
TR201702103A2 (en) 2017-02-13 2018-08-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi TABLET FORMS OF VILAZODONE HYDROCHLORIDE
TR201702104A2 (en) 2017-02-13 2018-08-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi VILAZODONE HYDROCHLORIDE PHARMACEUTICAL COMPOSITIONS
AU2018340376B2 (en) 2017-09-29 2022-09-01 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidine piperazine compound and use thereof
CN111454250B (en) * 2019-01-21 2021-05-07 华东理工大学 Multi-target active compound and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1075156A (en) * 1963-08-27 1967-07-12 Luso Farmaco Inst Substituted piperazines
US3468882A (en) * 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
JPH0465034A (en) * 1990-07-02 1992-03-02 Mitsubishi Electric Corp Manufacture of oxide superconducting wire
FR2670491B1 (en) 1990-12-14 1993-02-05 Adir NOVEL 1,4-DISUBSTITUTED PIPERAZINES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE4101686A1 (en) * 1991-01-22 1992-07-23 Merck Patent Gmbh INDOLDER DERIVATIVES
DE4127849A1 (en) * 1991-08-22 1993-02-25 Merck Patent Gmbh BENZODIOXAN DERIVATIVES
DK148392D0 (en) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocyclic Compounds
DE4333254A1 (en) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidines and piperazines

Also Published As

Publication number Publication date
RU94035660A (en) 1996-07-20
ZA947622B (en) 1995-05-16
KR950008510A (en) 1995-04-17
GR3024551T3 (en) 1997-12-31
JPH07149762A (en) 1995-06-13
HU9402806D0 (en) 1995-01-30
PL305216A1 (en) 1995-04-03
TW313569B (en) 1997-08-21
HUT71833A (en) 1996-02-28
UA34449C2 (en) 2001-03-15
CA2133152C (en) 2005-08-30
RU2132848C1 (en) 1999-07-10
NO306948B1 (en) 2000-01-17
SK118494A3 (en) 1995-05-10
CZ237094A3 (en) 1995-04-12
PL178137B1 (en) 2000-03-31
NO943616D0 (en) 1994-09-29
SK281793B6 (en) 2001-08-06
ATE153663T1 (en) 1997-06-15
CN1056610C (en) 2000-09-20
CA2133152A1 (en) 1995-03-31
AU7424494A (en) 1995-04-13
KR100341190B1 (en) 2002-11-13
DE4333254A1 (en) 1995-04-06
DE59402902D1 (en) 1997-07-03
JP4700017B2 (en) 2011-06-15
ES2105454T3 (en) 1997-10-16
AU679774B2 (en) 1997-07-10
JP4065034B2 (en) 2008-03-19
EP0648767B1 (en) 1997-05-28
EP0648767A1 (en) 1995-04-19
DK0648767T3 (en) 1997-12-22
HU218918B (en) 2000-12-28
CN1106811A (en) 1995-08-16
CZ293558B6 (en) 2004-06-16
JP2007119502A (en) 2007-05-17
US5532241A (en) 1996-07-02

Similar Documents

Publication Publication Date Title
NO943616D0 (en) Piperidine and piperazine
SE8101409L (en) CARBOSTYRIL DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
ZA953288B (en) Substituted pyridylpyrazoles
DK0429627T3 (en) Derivatives of quinoline-3-carboxanilides
FI906108A0 (en) SEROTONINANTAGONISTER, DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE CEILING MODEL.
ES2094204T3 (en) PIPERAZINE DERIVATIVES.
EP1029860A4 (en) Benzofuran derivatives
DK0958821T3 (en) Fat emulsion containing xanthine derivative
NO20012544L (en) Substituted benzo [de] isoquinoline-1,3-dione
DE59914993D1 (en) Diresorcinyltriazines as light stabilizers
ATE248814T1 (en) 16-ENE-VITAMIN D DERIVATIVES
FI922982A (en) 2-AMINOPYRIMIDINE-4-CARBOXAM DERIVATIVES, FRAMSTAELLNING AV DESSA OCH THERAPEUTIC ANALYSIS AV DESSA
ATE209204T1 (en) PIPERIDINE DERIVATIVES.
ATE201412T1 (en) PTERIDINE DERIVATIVES AS NO SYNTHASE INHIBITORS
DE69707672T2 (en) DIBENZO-OXAZEPINE AND DIOXEPINE DERIVATIVES AND THEIR USE AS ANTITUARY AGENTS
DE69706950T2 (en) Furoindolizine
DE3670487D1 (en) 4-AMINOPYRIMIDINE AND FUNGICIDES CONTAINING THEM.
SE7604152L (en) WAY TO PRODUCE NEW CHROMONE DERIVATIVES
DE60121817D1 (en) BLOCKADE OF SODIUM CHANNELS BY PHENOL DERIVATIVES
NO931602D0 (en) NEW ENANTIOMERS DERIVED FROM (S) -2-AMINO-2- (3,4-DICHLOROBENZYL) -1-PROPANOL
GR3007320T3 (en)

Legal Events

Date Code Title Description
MK1K Patent expired